The University of Tokyo and Eisai Co., Ltd. have announced a collaboration aiming for the development and drug discovery...
Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercia...
Marinomed Biotech AG, a Vienna-based biopharmaceutical company, develops groundbreaking treatment for autoimmune gastrit...
South Korea based Standigm Inc., an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, ...
Excelra, a global data science and data analytics company headquartered in India, has announced its collaboration with S...
Eisai Co., Ltd. announced on 10 June 2020 that it has committed the equivalent of 1 million USD in aid towards various a...
India-based Sun Pharmaceutical Industries Ltd (Sun Pharma) has received Indian regulatory approval to start clinical tri...
Roche, a global leading provider of pharmaceuticals and cancer treatments, today announced that the Health Sciences Auth...
Exyte, world-renowned for the design and construction of high tech facilities, and Univercells Technologies, a prov...
Hong Kong based Insilico Medicine has announced that it has entered into a research collaboration agreement with Ja...
Taiwan headquartered Senhwa Biosciences Inc announced that it has partnered with the US National Institutes of Health (N...
US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...
Hong Kong headquartered Insilico Medicine has announced that it has entered into a research collaboration with Boehringe...
There is no specific drug which can fight against COVID-19 yet. Developing a specific drug is quite tough. It is no...
Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...
The Centre for Digestive Disease (CDD) headed by Professor Thomas Borody has cured Crohn’s Disease as reported on ...
Pfizer Inc.on 9 April 2020, announced important advances in the battle against the global COVID-19 pandemic. Some o...
Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...
